Stephen C. Rubin

21.6k citations
276 papers · 15.3k indexed · 5 hit papers · h-index 62

Impact in

Papers in

Stephen C. Rubin

270 papers receiving 14.9k citations

Hit Papers

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial 2017 · 406 citations
406199120262002201450010001.5k2.0k2.5k

Peers

Stephen C. Rubin
Comparison fields: 5 of 160
  • Reproductive Medicine 6.4k
  • Obstetrics and Gynecology 2.6k
  • Oncology 6.0k
  • Immunology 3.6k
  • Surgery 3.6k
Replace Ross S. Berkowitz with:
Ross S. Berkowitz United States
Robert A. Burger United States
Jonathan S. Berek United States
Robert P. Edwards United States
Gunnar B. Kristensen Norway
Christian Marth Austria
Hys Ngan Hong Kong
Peter E. Schwartz United States
Sërgio Pecorelli Italy
Peter Kenemans Netherlands
Stephen C. Rubin relative to Ross S. Berkowitz United States Ross S. Berkowitz's profile →
Citations per field
00.5×1.5×2.2×
Ross S. Berkowitz · 1×
Citations per year

Countries citing papers authored by Stephen C. Rubin

Since Specialization
Citations

This map shows the geographic impact of Stephen C. Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen C. Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen C. Rubin more than expected).

Fields of papers citing papers by Stephen C. Rubin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen C. Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen C. Rubin. The network helps show where Stephen C. Rubin may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephen C. Rubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen C. Rubin Line = papers co-authored together Stephen C. Rubin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20206
2 20199
3 201813
4 201720
5 201653
6 201563
7 2015188
8 201111
9 201151
10 200831
11 200233
12 1998134
13
Cervical cancer and preinvasive neoplasia
199642
14 199329
15 199374
16 199263
17
Peritoneal sarcoidosis and elevated CA 125.
199114
18
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.
Hit paper breakdown →
1991647
19 198976
20 198968

About Stephen C. Rubin

Stephen C. Rubin is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Pathology and Forensic Medicine and Surgery, having authored 276 papers that have together received 15.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (133 papers), Intraperitoneal and Appendiceal Malignancies (63 papers), Endometrial and Cervical Cancer Treatments (52 papers), Uterine Myomas and Treatments (15 papers), Cervical Cancer and HPV Research (14 papers), BRCA gene mutations in cancer (13 papers), Cancer Treatment and Pharmacology (13 papers) and Family Support in Illness (12 papers). The work is most often cited by research in Reproductive Medicine (6.4k citations), Obstetrics and Gynecology (2.6k citations), Oncology (6.0k citations), Immunology (3.6k citations) and Surgery (3.6k citations). Stephen C. Rubin has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include George Coukos, Katia Schlienger, William J. Hoskins, John L. Lewis, Lin Zhang, Thomas B. Hakes, José R. Conejo-García, Antonis Makrigiannakis, Dionyssios Katsaros and Heidi J. Gray. Their work appears in journals such as Gynecologic Oncology, Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology, Cancer and Obstetrics and Gynecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026